These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Role of 24,25-dihydroxycholecalciferol in bone mineralization under hypokinesia in the rat].
    Author: Sergeev IN, Blazheevich NV, Belakovskiĭ MS, Spirichev VB, Ushakov AS.
    Journal: Kosm Biol Aviakosm Med; 1982; 16(5):74-7. PubMed ID: 6983003.
    Abstract:
    24,25-Dihydroxycholecalciferol, an active D3 vitamin metabolite, at a dose of 1.25 microgram/day/animal prevents bone osteoporotic changes, effectively stimulating the diaphyseal and epiphyseal mineralization, and corrects hypocalcemia of hypokinetic rats. 24,25(OH)2D3 at the above dose does not increase nephrocalcinosis or does not produce the toxic effect as measured by body mass variations.
    [Abstract] [Full Text] [Related] [New Search]